Adial Pharmaceuticals Expands Patent Portfolio With New US Patent For Lead Drug For Alcohol And Opioid Use Disorders
benzinga.com/general/health-care/25/05/45132313/exclusive-adial-pharmaceuticals-expands-patent-portfolio-with-new-us-patent-for-lead-drug-for
The United States Patent and Trademark Office (USPTO) issued patent number 12,274,692 to Adial Pharmaceuticals, Inc.’s (NASDAQ:ADIL) AD04 on Thursday.
The patent covers a method of treating alcohol-related diseases and opioid-related disorders using AD04 in genetically identified…
This story appeared on benzinga.com, 2025-05-01 12:02:41.